Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  PAREXEL International Corporation    PRXL   US6994621075

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company, which provides clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

The company operates its business through three segments: Clinical Research Services, PAREXEL Consulting & Medical Communication Services and Perceptive Informatics.

The Clinical Research Services segment includes services such as clinical trials management and biostatistics, data management, clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacovigilance, and investigator site services.

The PAREXEL Consulting & Medical Communication Services segment provides a spectrum of market development, product development and targeted communications services in support of product launch.

The Perceptive Informatics segment provides information technology solutions designed to improve client's product development processes.

The segments portfolio of products and services includes ClinPhone RTSM, IMPACT CTMS, DataLabs EDC, web-based portals, systems integration, electronic patient reported outcomes and LIQUENT InSight Regulatory Information Management platform.PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1982 and is headquartered in Waltham, MA.

Number of employees : 15 560 persons.
Sales per Businesses
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
Clinical Research Services1,03964.2%1,30465.3%1,45564.2%
Perceptive190.6811.8%228.3511.4%267.9011.8%
Paraxel Consulting and Medical Communications Services167.1310.3%202.5210.1%216.189.5%
Sales per Regions
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
The Americas635.2939.3%867.0043.4%970.8942.8%
Europe, Middle East & Africa555.4734.3%624.0131.3%709.1431.3%
Asia/Pacific205.7512.7%243.4312.2%259.3311.4%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA591982Chairman & Chief Executive Officer
Mark A. Goldberg, MD541997President & Chief Operating Officer
Ingo Bank, MBA462013Chief Financial Officer & Senior Vice President
Thomas Senderovitz, MD49-Senior Vice President-Clinical Research Services
Peter Steiger, PhD-2014Chief Scientific Officer & Vice President
Sy Pretorius, MD--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA621986Independent Director
Pat J. Fortune PhD, MBA671996Independent Director
Richard L. Love702002Independent Director
Ellen M. Zane622006Independent Director
Shareholders
NameShares%
Wellington Management Co. LLP 5,871,30810.7%
BlackRock Fund Advisors 4,572,9428.36%
The Vanguard Group, Inc. 4,182,8077.64%
Fisher Asset Management LLC 2,475,2744.52%
Neuberger Berman LLC 1,815,4223.32%
Fidelity Management & Research Co. 1,737,7903.18%
Schroder Investment Management North America, Inc. 1,615,0822.95%
Geneva Capital Management Ltd. 1,394,8682.55%
SSgA Funds Management, Inc. 1,302,6292.38%
RBC Global Asset Management (US), Inc. 1,126,2322.06%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
PHARMACYCLICS, IN..
INCYTE CORPORATIO..
QUINTILES TRANSNA..
PUMA BIOTECHNOLOG..
-
ALNYLAM PHARMACEU..
ALKERMES PLC
UNITED THERAPEUTI..
QIAGEN NV
ISIS PHARMACEUTIC..
COVANCE INC.
SEATTLE GENETICS,..
ICON PLC
PAREXEL INTERNATI..
TECHNE CORPORATIO..
CHARLES RIVER LAB..
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
SYNAGEVA BIOPHARM..
MORPHOSYS AG
BB BIOTECH AG
Sector Biotechnology & Medical Research
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451-1111

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF